Fifteen-Minute Consultation: Approach to the Adolescent Presenting with Hirsutism

    January 2023 in “ Archives of Disease in Childhood Education & Practice ”
    Alexandra Selina Cross, Manar Moustafa, Charlotte Elder
    Image of study
    TLDR Hirsutism in teens is often due to polycystic ovarian syndrome and needs careful assessment and support.
    Hirsutism, characterized by unwanted terminal hair growth in androgen-dependent areas, is frequently encountered by paediatricians, dermatologists, and endocrinologists. The most common cause is polycystic ovarian syndrome, though its diagnosis in adolescents can be difficult due to overlapping features with normal adolescent development. Other rare causes include non-classic congenital adrenal hyperplasia and androgen-secreting tumors. Hirsutism can significantly impact psychological well-being. This article outlines the causes of hirsutism, introduces a new assessment tool, and provides guidance on investigation and management strategies, including recommendations for psychological support.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 24 results

      community I am having Success with RU58841 and 1mm Derma Roller

      in Microneedling  19 upvotes 2 years ago
      A user reported success with RU58841 and a 1mm derma roller for hair regrowth, noting significant improvement in hair density and reduced scalp visibility. They also mentioned using minoxidil and black castor oil in the past, with mixed results.

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  13 upvotes 9 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Related Research

    3 / 3 results